| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $60,431,873 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM133565 | The Discovery of Molecules and Mechanisms of the Rhomboid Superfamily | 000 | 7 | NIH | 12/16/2025 | $407,958 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI169892 | Defining the resistome in P. falciparum: evolution and mechanism | 000 | 4 | NIH | 12/16/2025 | $1,122,490 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI176639 | Innate immunity against viral infection in intestinal epithelial cells of C. elegans | 000 | 4 | NIH | 12/19/2025 | $385,964 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069536 | CURE CTU | 000 | 20 | NIH | 12/22/2025 | $674,268 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F30AI176696 | Investigating the mechanism of infection and therapeutic potential of Pseudomonas nucleus-forming phages | 000 | 3 | NIH | 11/25/2025 | $43,120 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG077202 | COVID-19-related blood-brain barrier and microstructural brain injury; Sex differences and synergy with Alzheimer's disease risk | 000 | 4 | NIH | 12/3/2025 | $679,504 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG074928 | Assessment of Language and Cognition in Older Deaf Signers | 001 | 4 | NIH | 12/23/2025 | $650,295 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R21AI180901 | Identification of Plasmacytoid Dendritic Cell Regulators | 000 | 2 | NIH | 11/25/2025 | $239,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI179952 | Tissue-specific adaptions to promote localized T cell memory | 000 | 3 | NIH | 12/3/2025 | $339,015 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI179952 | Tissue-specific adaptions to promote localized T cell memory | 000 | 3 | NIH | 12/3/2025 | $277,376 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG091503 | Blood-brain barrier and microstructural brain biomarkers of ARIA and treatment outcomes with anti-amyloid immunotherapy for Alzheimer's disease | 000 | 2 | NIH | 1/15/2026 | $710,050 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS124637 | The Contribution of Microglial MEF2C to Brain Development | 000 | 5 | NIH | 12/23/2025 | $368,037 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS132533 | Pro-Survival Responses to Neurocellular Stress | 000 | 3 | NIH | 12/22/2025 | $433,371 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R00CA267181 | Optimal early colorectal cancer screening initiation | 000 | 4 | NIH | 12/23/2025 | $224,101 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA256973 | Molecular Imaging Probe(s) for Optical Surgical Navigation of Pancreatic Cancer | 000 | 5 | NIH | 1/14/2026 | $405,011 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01MH135147 | Cognitive Consequences of Obstructive Sleep Apnea in Schizophrenia: An Investigation of Inflammatory Mechanisms | 000 | 3 | NIH | 12/24/2025 | $759,302 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | K23AG080023 | Impact of Hourly Neurochecks in Critically Ill Older Adults | 000 | 3 | NIH | 1/14/2026 | $196,498 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01NS139877 | Optimization of Transparent Microelectrode Arrays for Large-scale Multimodal Monitoring of Neural Activity | 000 | 2 | NIH | 1/19/2026 | $1,221,187 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA279813 | New tools for quantitative non-invasive recording of biochemical signals | 000 | 3 | NIH | 1/20/2026 | $595,170 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS119525 | The Function of the Cytoplasmic tRNA Repertoire in the Cellular and Molecular Homeostasis of the Mammalian Brain | 000 | 5 | NIH | 12/30/2025 | $387,517 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01HD111650 | Androgen effects on the reproductive neuroendocrine axis | 000 | 3 | NIH | 1/16/2026 | $584,117 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01EB036986 | Bioengineering of Enucleated Cell Therapeutics for Treating Inflammatory Diseases | 000 | 2 | NIH | 1/16/2026 | $382,184 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI168993 | Enabling synthetic biology through single cell functional genomics | 000 | 5 | NIH | 1/15/2026 | $434,611 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG098026 | Developing robust zero-shot AI models for anti-aging antibody design | 000 | 1 | NIH | 1/16/2026 | $615,390 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI179098 | Mechanisms of vaccine interference by S. aureus-induced imprints | 000 | 3 | NIH | 1/15/2026 | $687,067 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DA036612 | Role of novel VTA neurons in addiction-related behaviors | 000 | 13 | NIH | 1/16/2026 | $477,765 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37NS076896 | Mechanisms of Prion Spread and Neuronal Toxicity | 000 | 14 | NIH | 1/16/2026 | $539,519 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA289833 | Mechanisms of Radiation-Induced Neurocognitive Decline (MIND): Longitudinal Study of Imaging Biomarkers and Risk and Resilience Factors Underlying Cognitive Phenotypes in Patients with Glioma | 000 | 2 | NIH | 1/16/2026 | $588,699 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA266486 | Role of breast cancer secreted miRNA in brain metastasis | 000 | 5 | NIH | 1/7/2026 | $369,571 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI163327 | Suppressing Inflammation by Blocking IKK Oligomer | 000 | 5 | NIH | 1/15/2026 | $529,328 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | NUR3DD000101 | Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) in San Diego County | 00 | 4 | CDC | 1/5/2026 | $449,971 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01NS130831 | Structural mechanisms of autoimmune diseases targeting cys-loop receptors | 000 | 5 | NIH | 1/16/2026 | $592,722 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37AI052453 | Cathelicidin in Skin Immunity | 000 | 23 | NIH | 1/15/2026 | $602,803 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069432 | UCSD Collaborative Clinical Trials Unit | 000 | 20 | NIH | 1/7/2026 | $1,664,282 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U24DK138512 | An interactive resource to generate and provide integrated knowledge of the human pancreas | 000 | 3 | NIH | 1/8/2026 | $1,960,275 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | K08AI187716 | Building an atlas of B cell mediated protective immunity to alphaviruses | 001 | 2 | NIH | 1/7/2026 | $170,639 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01EY029342 | Kinase Multitargeting for Glaucoma Neuroprotection | 000 | 8 | NIH | 1/22/2026 | $395,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01DK132242 | Integrin αEβ7-dependent IgA transcytosis during homeostasis and IBD | 000 | 4 | NIH | 1/22/2026 | $642,287 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AG077579 | Understanding Biological and Lifestyle Contributions to Alzheimer's Disease Pathology and Clinical Profiles in Black Women: Defining Prevention Targets in High Risk Groups | 000 | 4 | NIH | 1/22/2026 | $682,881 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01MH132112 | Social Cognitive Mechanisms Underlying Disclosure and Help Seeking Behavior in Late-Life Suicide | 000 | 4 | NIH | 1/21/2026 | $750,155 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R21DC022690 | Exploring the Blood-Labyrinthine Barrier: A Novel Approach with hiPSC-Derived Spheroids and Assembloids | 000 | 1 | NIH | 12/26/2025 | $438,244 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | F31NS147610 | Metabolic Plasticity and Neuronal Resilience: Unraveling Adaptive Responses to Chronic mtDNA Damage | 000 | 1 | NIH | 1/21/2026 | $42,870 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM130389 | Lessons Learned from PKA: Assembly of Dynamic Macromolecular Switches | 000 | 9 | NIH | 1/22/2026 | $543,871 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | K08NS123543 | Defining the forebrain neurophysiological representation of pain | 000 | 4 | NIH | 12/22/2025 | $195,561 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01AI173689 | Identifying the Most Effective Adjuvant(s) for Leading Group A Streptococcal Vaccine Antigens in Preclinical Mouse and Nonhuman Primate Models | 001 | 4 | NIH | 1/21/2026 | $54,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01CA174869 | Regulation of Tumor Invasion and Metastasis by Matrix Stiffness | 000 | 10 | NIH | 1/22/2026 | $327,395 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R00NS121511 | Elucidating the role of RNA oxidation on amyotrophic lateral sclerosis onset and progression | 000 | 5 | NIH | 12/29/2025 | $341,403 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM157217 | Develop Multi-modal Foundation Models for Sepsis Early Detection | 000 | 2 | NIH | 1/22/2026 | $308,096 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R01MH127077 | Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism | 000 | 5 | NIH | 1/21/2026 | $778,227 |
|
